Global Precision Medicine Market Research Report 2022-2027
© 2022 IMARC All Rights Reserved
Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
About IMARC Group
Report Description
International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Precision Medicine Market Outlook 2022-2027: The latest report by IMARC Group, titled “Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global precision medicine market size reached US$ 61.0 Billion in 2021. Precision medicine or personalized medicine refers to the emerging approach of preventive healthcare, which focuses on the overall sequencing of the human genome to treat diseases. The approach allows doctors and physicians to study individual responses to therapy, individual profile at a genetic level, as well as their lifestyle and environment. Precision medicine offers various advantages such as improving care quality; eliminating trial-anderror inefficiencies; reducing time, cost, and failure rates of pharmaceutical clinical trials; and guiding the therapy for chronic diseases. It is also increasingly used for predicting the risk of passing on genetic disorders to offsprings. Request for a PDF sample of https://www.imarcgroup.com/precision-medicine-market/requestsample
this
report:
Report Description and Highlights
Report Description
Precision Medicine Market Drivers/Constraints: The market is primarily driven by the rising incidences of cancer. The increasing approval of drug and companion diagnostic assays is also propelling the growth of the market. Precision medicine facilitates the cost-effective profiling of DNA, thereby increasing the penetration of high-throughput sequencing platforms. In recent years, there has been an exponential growth in targeted molecules in the pipeline for specific applications, especially in oncology. Besides this, the recent outbreak of coronavirus disease (COVID-19) pandemic has led to the increased utilization of precision medicine techniques to understand the susceptibility, impact, and potential therapies associated with the virus. Furthermore, the integration of biotech and pharma industries with big data healthcare companies helps analyze the patient electronic health record and provides improved clinical decision support, which is fueling the market growth. Moreover, key manufacturers are patenting molecules, along with their companion diagnostics, to achieve a competitive edge and enhance profit margins, which is positively influencing the demand for precision medicine in the healthcare industry. Looking forward, the market value is expected to grow at a CAGR of 10.1% during the forecast period (2022-2027). View Report TOC, Figures and Tables: https://www.imarcgroup.com/precision-medicine-market
Report Description and Highlights
Report Description Key Market Segmentation
The research report includes the following segments:
Breakup by Product: • • •
Consumables Instruments Services
Breakup by Technology: • • • • • •
Big Data Analytics Bioinformatics Gene Sequencing Drug Discovery Companion Diagnostics Others
Report Description and Highlights
Report Description Breakup by Application: •Oncology •Central Nervous System (CNS) •Immunology •Respiratory Medicine •Infections •Others
Breakup by End User: •Hospitals and Clinics •Diagnostic Centers •Pharma and Biotech Companies •Healthcare IT Firms •Others
Report Description and Highlights
Report Description Breakup by Region: •North America •Asia Pacific •Europe •Latin America •Middle East and Africa
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. click here: https://www.imarcgroup.com/request?type=report&id=4567&flag=E
Report Description and Highlights
Report Description Competitive Landscape:
•AstraZeneca plc, •Bayer AG, •bioMérieux SA, •Bristol-Myers Squibb Company, •Eli Lilly and Company, •F. Hoffmann-La Roche AG, •Illumina Inc., •Laboratory Corporation of America Holdings, •Merck KGaA, Novartis AG, •Pfizer Inc., •Qiagen N.V., • Quest Diagnostics Incorporated •Thermo Fisher Scientific Inc.
Key Questions Answered in the Report
Report Description
1. How has the global precision medicine market performed so far and how will it perform in the coming years? 2. What has been the impact of COVID-19 on the global precision medicine market? 3. What are the key regional markets? 4. What is the breakup of the market based on the product? 5. What is the breakup of the market based on the technology? 6. What is the breakup of the market based on the application? 7. What is the breakup of the market based on the end user? 8. What are the various stages in the value chain of the industry? 9. What are the key driving factors and challenges in the industry? 10. What is the structure of the global precision medicine market and who are the key players? 11. What is the degree of competition in the industry?
Report Description 1
Preface
2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3
Executive Summary
4 Introduction 4.1 Overview 4.2 Key Industry Trends
Table of Contents
Report Description
Table of Contents
5 Global Precision Medicine Market 5.1 5.2 5.3 5.4
Market Overview Market Performance Impact of COVID-19 Market Forecast
6 Market Breakup by Product 6.1 Consumables 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/precision-medicine-market/toc
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
A partial List of
We are the trusted business partners to the
of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions
Report Description and Highlights
Report Description
© 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com